In brief
The Defense Department announced that all personnel aged 30 and above will undergo annual testosterone testing. Those with low levels may receive voluntary hormone replacement. The policy, partly driven by a broader Trump-era push, has sparked debate over its focus on a "manly" military image, possible risks of treatment, and whether women will have access.
The U.S. Defense Department announced on [date] that every service member aged 30 and above will receive annual testosterone testing as part of routine health evaluations.
If a low level is detected, the individual will be offered voluntary testosterone replacement treatment, according to a statement from Secretary Pete Hegseth.
Under-30 personnel can opt into screening, but the policy does not clarify whether hormone‑replacement will extend to female service members.
The directive reflects a broader Trump‑era push to ease prescribing testosterone to men and is seen by some analysts as a push to create a "manly" military.
Health experts caution that while testosterone supports energy and mood, replacement therapy carries risks and should be monitored carefully.
